Tellgen

Shanghai Tellgen Life Sciences Co., Ltd. (Tellgen Corporation) is a Chinese in vitro diagnostics (IVD) company founded in 2003 and headquartered in Shanghai, focused on the research, development, manufacture, and distribution of high-end diagnostic reagents and instruments. Its portfolio spans tumor markers, HPV detection, autoimmune antibodies, infectious disease, thrombosis and reproductive-health assays across flow-fluorescence, chemiluminescence, real-time PCR / molecular, and clinical-chemistry platforms (TESMI analyzer family). The company was listed on the Shenzhen Stock Exchange ChiNext board in April 2017 (ticker 300642) and counts Qiming Venture Partners among its early investors. Tellgen is a medical-device and laboratory-reagent manufacturer and publishes no public developer API, SDK, or developer portal.

Tellgen is profiled on the APIs.io network. Tagged areas include Company, In Vitro Diagnostics, IVD, Medical Devices, and Diagnostics.

🌐 Visit website 📡 Source on GitHub
2.2/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-20 · rubric v0.12.0
0 APIs
CompanyIn Vitro DiagnosticsIVDMedical DevicesDiagnosticsLife SciencesHealthcareReagentsMolecular Diagnostics

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-20 · rubric v0.12.0
Composite quality — 2.2/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 0.0 / 17
Access Clarity 0.0 / 17
Operational Transparency 0.0 / 11
Contract Governance 0.0 / 10
Discoverability 4.3 / 9
Regulatory Posture 0.0 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
Documented Reversibility 0 / 6
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/tellgen: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Company 1

The organization behind the API

Website
Website

Source (apis.yml)

apis.yml Raw ↑ 
aid: tellgen
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/tellgen.png
name: Tellgen
description: Shanghai Tellgen Life Sciences Co., Ltd. (Tellgen Corporation) is a Chinese in vitro diagnostics (IVD) company
  founded in 2003 and headquartered in Shanghai, focused on the research, development, manufacture, and distribution of high-end
  diagnostic reagents and instruments. Its portfolio spans tumor markers, HPV detection, autoimmune antibodies, infectious
  disease, thrombosis and reproductive-health assays across flow-fluorescence, chemiluminescence, real-time PCR / molecular,
  and clinical-chemistry platforms (TESMI analyzer family). The company was listed on the Shenzhen Stock Exchange ChiNext
  board in April 2017 (ticker 300642) and counts Qiming Venture Partners among its early investors. Tellgen is a medical-device
  and laboratory-reagent manufacturer and publishes no public developer API, SDK, or developer portal.
url: https://raw.githubusercontent.com/api-evangelist/tellgen/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- qiming
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-21'
tags:
- Company
- In Vitro Diagnostics
- IVD
- Medical Devices
- Diagnostics
- Life Sciences
- Healthcare
- Reagents
- Molecular Diagnostics
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://www.tellgen.com
x-enrichment:
  date: '2026-07-21'
  status: nochange
  artifacts_added: 0
  pass: local-v1